Urol. praxi. 2024;25(4):210-212 | DOI: 10.36290/uro.2024.073
Ambulatory parenteral antibiotic therapy in urology: innovations and perspectives
- Klinika infekčních nemocí a cestovní medicíny 2. LF UK a FN Motol, Praha
The review article addresses the issues of outpatient parenteral antibiotic therapy (OPAT) in urology. OPAT is a treatment modality that allows intravenous administration of antibiotics in an outpatient setting. Urology is one of the fields where OPAT can be utilized, most commonly to treat urinary tract infections caused by multidrug-resistant bacteria (e. g., ESBL-producing strains) in patients whose health condition does not require hospitalization. OPAT can be implemented in several ways: administering long-acting antibiotics (ceftriaxone, ertapenem, gentamicin, and amikacin) once daily at the clinic or the application of various antibiotics continuously using an elastomeric pump. Abroad, it is also common to provide OPAT at home, most often by home care nurses or even by trained patients or their relatives.
Keywords: OPAT, antibiotics, urinary tract infections, outpatient therapy, multidrug-resistant bacteria.
Accepted: November 11, 2024; Published: November 25, 2024 Show citation
PDF will be unlocked 25.11.2025 |
References
- Štefan M, Dlouhý P. OPAT - ambulantní parenterální antimikrobiální terapie. Doporučený postup Společnosti infekčního lékařství ČLS JEP [Internet]. 17-05-2023 [cit. 17-05-2024]. Available from: https://infektologie.cz/Standardy/OPAT_DP_2023_05_17-2.pdf.
- Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54(3):358-630.
Go to original source... - Norris AH, Shrestha NK, Allison GM, et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis. 2019;68(1):e1-e35. Go to original source...
Go to PubMed... - Champman ALN, Patel S, Horner C, et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist. 2019;1:dlz026. Go to original source... Go to PubMed...
- Holub M. Ambulantní parenterální antibiotická terapie. Čas Lék Čes. 2016;155:21-24.
- Shakoor S, Durojaiye OC, Collini PC. Outcomes of outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections - a single center retrospective cohort study. Clinical Infection in Practice. 2023;17:100212. Go to original source...
- Štefan M. Léčba infekcí močových cest v éře antibiotické rezistence. Urol. praxi. 2017;18:17-20. Go to original source...
- Cho SY, Choi SM, Park SH, et al. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Korean J Intern Med. 2016;31(1):156-161. Go to original source... Go to PubMed...
- Bazaz R, Chapman ALN, Winstanley TG. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. J Antimicrob Chemother. 2010;65(7):1510-1513. Go to original source... Go to PubMed...
- Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023;18:ciad428. Go to original source... Go to PubMed...
- Candel FJ, Julián-Jiménez A, González-Del Castillo J. Current status in outpatient parenteral antimicrobial therapy: a practical view. Rev Esp Quimioter. 2016;29:55-68.